Vanda Pharmaceuticals reported $71.99M in Current Liabilities for its second fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Current Liabilities Change
Acadia Pharmaceuticals ACAD:US $ 95.33M 14.04M
Agios Pharmaceuticals AGIO:US $ 60.65M 35.85M
Akebia Therapeutics AKBA:US $ 165.6M 7.08M
Alnylam Pharmaceuticals ALNY:US $ 554.65M 59.82M
Anika Therapeutics ANIK:US $ 41.37M 5.61M
Arena Pharmaceuticals ARNA:US $ 64.84M 17.33M
Arrowhead Research ARWR:US $ 195.43M 28.25M
AstraZeneca AZN:LN 22222M 709M
Bluebird Bio BLUE:US $ 247.76M 41.45M
Bristol Myers Squibb BMY:US $ 21460M 2469M
Clovis Oncology CLVS:US $ 173.88M 0.64M
Eli Lilly And LLY:US $ 13682M 1411.2M
Enanta Pharmaceuticals ENTA:US $ 28.62M 2.01M
Esperion Therapeutics ESPR:US $ 82.64M 15.25M
Halozyme Therapeutics HALO:US $ 114.25M 6.83M
Heron Therapeutics HRTX:US $ 82.14M 18.77M
Insmed INSM:US $ 99.66M 18.26M
Intercept Pharmaceuticals ICPT:US $ 145.28M 0.95M
Ligand Pharmaceuticals LGND:US $ 52.5M 43.31M
Merk MRK:US $ 21906M 4455M
Minerva Neurosciences NERV:US $ 4.44M 1.08M
Moderna Inc MRNA:US 8.84B 399M
Novartis NVS:US $ 29880M 247M
Ptc Therapeutics PTCT:US $ 290.96M 40.01M
Puma Biotechnology PBYI:US $ 137.9M 2.51M
Sangamo Biosciences SGMO:US $ 136.94M 4.1M
Takeda 4502:JP Y 1644766M 128410M
Teva Pharmaceutical TEVA:IT 11.82B 866M
Ultragenyx Pharmaceutical RARE:US $ 127.07M 0.02M
Vanda Pharmaceuticals VNDA:US $ 71.99M 10.2M
Veracyte VCYT:US $ 36.1M 3.4M